1.Role of matrix metalloproteinases in regulating neurovascular unit affect the prognosis of chronic compression of spinal cord injury: current status.
Chinese Journal of Surgery 2015;53(9):718-720
Chronic spinal cord compression is the common clinical prognosis with various outcomes, but the affecting factors and mechanisms still remain unexplored. The structure and function of neurovascular unit manifest great significance in the central nervous system diseases. This paper discusses matrix metalloproteinase (MMP) impact on the stability of the neural vascular unit, by directly decomposing extracellular matrix, inducing the glial cell migration, activating angiogenesis, regulating function of blood spinal cord barrier, and put forward the MMP may be the key points in regulation of spinal cord neurovascular unit structure and function change to affect the outcome of chronic oppressive cervical spinal cord.
Cell Movement
;
Humans
;
Matrix Metalloproteinases
;
physiology
;
Nerve Compression Syndromes
;
diagnosis
;
enzymology
;
Neurons
;
cytology
;
Prognosis
;
Spinal Cord Injuries
;
diagnosis
;
enzymology
2.Increased expression of neuronal nitric oxide synthase in astrocytes and macrophages in the spinal cord of Lewis rats with autoimmune encephalomyelitis.
Journal of Veterinary Science 2001;2(3):195-199
Neuronal nitric oxide synthase (nNOS) is constitutively expressed in neurons of the central nervous system, where it plays a physiological role in neurotransmission. In this study, we examined the functional role of nNOS in experimental autoimmune encephalomyelitis(EAE). The effects of the specific nNOS inhibitor 7-nitroindazole on normal and EAE rats were studied by immunohistochemistry and Western blot analysis. We found that nNOS is constitutively expressed in the spinal cords of normal rats, whilst in the spinal cords of EAE rats, nNOS expression slightly increased, concomitant with the infiltration of T cells and macrophages. Immunohistochemical studies showed that nNOS expression in macrophages and astrocytes increased at the peak stage of EAE and declined thereafter. Treatment with 7-nitroindazole (30 mg/kg) significantly delayed the onset of EAE paralysis, but had no effect on either the incidence or the severity of the paralysis. These findings suggest that nNOs inhibition has a limited role in the induction of rat EAE, and that constitutive nNOS in the spinal cord functions as a novel neurotransmitter, rather than a pro-inflammatory agent.
Animals
;
Astrocytes/*enzymology
;
Blotting, Western
;
Encephalomyelitis, Autoimmune, Experimental/drug therapy/*enzymology
;
Enzyme Inhibitors/therapeutic use
;
Immunohistochemistry
;
Indazoles/therapeutic use
;
Macrophages/*enzymology
;
Male
;
Nitric Oxide Synthase/antagonists&inhibitors/*metabolism
;
Rats
;
Rats, Inbred Lew
;
Spinal Cord/cytology/*enzymology